A Multistate Markov Model Based on CD4 Cell Count for HIV/AIDS Patients on Antiretroviral Therapy (ART)

No abstract is available for this paper.

• Publication year

  2013

• Venue

  International journal of statistics in medical research

• Publication date

  2013-04-30

• Fields of study

  Medicine

• Identifiers
  DOI 10.6000/1929-6029.2013.02.02.08
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Multi-State Models for Panel Data: The msm Package for R

  2011cited by this paper
• The Application of Multistate Markov Models to HIV Disease Progression

  2011cited by this paper
• Modelling the Impact of Antiretroviral Therapy on the Epidemic of HIV

  2011cited by this paper
• Mortality in HIV infected individuals in Pune, India

  2011cited by this paper
• Estimating the impact of antiretroviral therapy: regional and global estimates of life-years gained among adults

  2010cited by this paper
• Two-year treatment outcomes of patients enrolled in India's national first-line antiretroviral therapy programme.

  2010cited by this paper
• UvA-DARE ( Digital Academic Repository ) HIV disease progrssion in injecting drug users : epidemiological studies

  2009cited by this paper
• Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy

  2008cited by this paper
• Effectiveness and Safety of Generic Fixed-Dose Combination of Tenofovir/Emtricitabine/Efavirenz in HIV-1-Infected Patients in Western India

  2008cited by this paper
• Improvement in CD 4 counts in HIV positive patients treated with HAART and antitubercular drugs: an observational study from North India.

  2007cited by this paper
• Causal Pathways of the Effects of Age and the CCR5-Δ32, CCR2-64I, and SDF-1 3′A Alleles on AIDS Development

  2005cited by this paper
• Clinical profile of HIV in India.

  2005cited by this paper
• Gender difference in HIV‐1 RNA viral loads

  2005cited by this paper
• The safety, tolerability and effectiveness of generic antiretroviral drug regimens for HIV-infected patients in south India

  2003cited by this paper
• Initial plasma HIV-1 RNA levels and progression to AIDS in women and men.

  2001cited by this paper
• HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy

  2001cited by this paper
• Effect of Gender, Age, Transmission Category, and Antiretroviral Therapy on the Progression of Human Immunodeficiency Virus Infection Using Multistate Markov Models

  1998cited by this paper
• The incubation period to AIDS in injecting drug users estimated from prevalent cohort data, accounting for death prior to an AIDS diagnosis

  1998cited by this paper
• Sex differences in HIV-1 viral load and progression to AIDS.

  1998cited by this paper
• Effects of age at seroconversion and baseline HIV RNA level on the loss of CD4+ cells among persons with hemophilia

  1998cited by this paper
• Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection

  1997cited by this paper
• Importance of age at infection with HIV-1 for survival and development of AIDS in UK haemophilia population. UK Haemophilia Centre Directors' Organisation.

  1996cited by this paper
• Comparison of the declines in CD4 counts in HIV-1-seropositive female sex workers and women from the general population in Nairobi, Kenya.

  1995cited by this paper
• Effect of age and exposure group on the onset of AIDS in heterosexual and homosexual HIV‐infected patients

  1994cited by this paper
• Statistical analysis of the stages of HIV infection using a Markov model.

  1989cited by this paper
• A Markov model for analysing cancer markers and disease states in survival studies.

  1986cited by this paper
• The Analysis of Panel Data under a Markov Assumption

  1985cited by this paper
• Theory of stochastic processes

  1974cited by this paper

• Supporting antiretroviral therapy uptake and adherence: the SUPA research programme and RCT

  2025cites this paper
• Health Economic Benefits of Implementing Nucleic Acid Testing in Addition To Serology for Blood Transfusion Safety in India: a Cost-Effectiveness Analysis

  2025cites this paper
• Time‐Homogeneous Markov Modeling of HIV Progression in Patients Receiving Antiretroviral Therapy Treatment in the Ashanti Region, Ghana

  2025cites this paper
• Cost-effectiveness of an interactive voice response system for improving retention in care and adherence to antiretroviral therapy among young adults in Uganda

  2024cites this paper
• Application of Exponential Distribution in Modeling of State Holding Time in HIV/AIDS Transition Dynamics

  2024cites this paper
• Modeling Monthly Migraine-Day Distributions Using Longitudinal Regression Models and Linking Quality of Life to Inform Cost-Effectiveness Analysis: A Case Study of Fremanezumab in Japanese-Korean Migraine Patients

  2023cites this paper
• Effectiveness of Antiretroviral Treatment on the Transition Probability of Immunological State of HIV/AIDS Patients: A Markov Chain Model on the Iranian “National Registry of HIV/AIDS Care” Database

  2023cites this paper
• Estimation of Quality Adjusted Life Years (QALYs) for HIV Patients on Art in Kenya Using Proxy Utility Function

  2022cites this paper
• Markov modelling of viral load adjusting for CD4 orthogonal variable and multivariate conditional autoregressive mapping of the HIV immunological outcomes among ART patients in Zimbabwe

  2021cites this paper
• A STOCHASTIC MODEL FOR CHRONIC KIDNEY DISEASE

  2021cites this paper
• A Study Comparing Cost-Effectiveness of Combination Therapy for Preventing Opportunistic Infections Among Human Immunodeficiency Virus-Infected Adults on Antiretroviral Therapy.

  2021cites this paper
• LSHTM Research Online

  2020cites this paper
• Evaluation of CD4 count in patients receiving ART treatment in a tertiary rural hospital of India

  2020cites this paper
• Continuous-time Markov modelling of the effects of treatment regimens on HIV/AIDS immunology and virology

  2019influential citation
• Migraine day frequency in migraine prevention: longitudinal modelling approaches

  2019cites this paper
• Cost-Effectiveness of Three Alternative Boosted Protease Inhibitor-Based Second-Line Regimens in HIV-Infected Patients in West and Central Africa

  2019influential citation
• بررسی مقایسهای توان پیشگویی بروز ایدز در افراد آلوده به HIV به وسیلهی مدل مارکوف براساس دو معیار WHO و CDC در دستهبندی سلولهای CD4

  2019cites this paper
• Comparative study of predictive ability of AIDS incidence in HIV positive people using Markov model according to two criteria, WHO and CDC in CD4 cell categorization

  2019cites this paper
• A Multi-State Markov Model for the Progression of Chronic Kidney Disease Kronik

  2019cites this paper
• A comparison of the time homogeneous and time non-homogeneous markov models for monitoring HIV/AIDS disease progression: Results from patients on ART.

  2019cites this paper
• HIV Disease Progression Among Antiretroviral Therapy Patients in Zimbabwe: A Multistate Markov Model

  2019cites this paper
• A New Approach to Evaluate Quality Adjusted Life Years using Proxy Utility Function - An Application to HIV/ AIDS Data

  2019cites this paper
• A Stochastic Model for Assessing the Efficacy of Antiretroviral Therapy (ART) on Farmers Living with HIV/AIDS

  2019cites this paper
• Multistate Markov model for predicting the natural disease progression of type 2 diabetes based on hemoglobin A1c

  2018cites this paper
• Time-homogeneous Markov process for HIV/AIDS progression under a combination treatment therapy: cohort study, South Africa

  2018cites this paper
• A MODEL FOR ASSESSING THE PROGRESS AND PREDICTING THE EFFICACY OF ANTIRETROVIRAL THERAPY ( ART )

  2018cites this paper
• A Markov model to estimate mortality due to HIV/AIDS using CD4 cell counts based states and viral load: a principal component analysis approach

  2018influential citation
• On the estimation of misclassification probabilities of chronic kidney disease using continuous time hidden Markov models

  2018cites this paper
• Novel Approaches in Antiretroviral Therapies Retention and Demand Estimation for AIDS patients in Zimbabwe

  2016influential citation
• Modeling trend of the immune system in HIV positive people treated with antiretroviral drugs, using Markov model

  2015cites this paper
• مدلسازی روند تغییرات سیستم ایمنی در افراد آلوده به ویروس HIV تحت درمان با داروهای ضدرتروویروسی بهوسیله مدل مارکوف

  2015cites this paper
• Models for predicting readmissions in heart failure patients : a comparison between Lombardia and England

  2015cites this paper